{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT02614131: Phase 1 Interventional Terminated Healthy
(2015)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03945253: Phase 1 Interventional Completed Advanced Solid Tumors
(2019)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04033432: Phase 2 Interventional Active, not recruiting Castration Levels of Testosterone
(2019)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01577745: Phase 1 Interventional Completed Solid Tumors
(2012)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02954796: Phase 1 Interventional Terminated Multiple Myeloma
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02791334: Phase 1 Interventional Active, not recruiting Solid Tumor
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03221348: Phase 1 Interventional Unknown status Follicular Lymphoma
(2018)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04203641: Phase 1/Phase 2 Interventional Recruiting Pancreas Cancer
(2019)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02576548: Phase 1 Interventional Completed HER2 Expressing Breast or Gastric/Stomach Cancers
(2015)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02740270: Phase 1 Interventional Completed Solid Tumors
(2016)
Source URL:
Class:
CONCEPT